Evidence map›Paper›PMID 32385544›Full record

SynthesisEuropean journal of clinical pharmacology2020

Dexmedetomidine for prevention of propofol injection pain upon induction of anesthesia: a meta-analysis.

Liting Ji, Weihua Sun, Yunping Lan, Changxing Xia, Gongmin Yu, Qinghua Wu, Shufen Yang, Xiaofeng Xu

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in European journal of clinical pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Chloroprocaine EDJournal of pain research · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Liting JiDepartment of Anesthesiology, People's Hospital of Quzhou, No. 2 Zhong Lou Di, Kecheng District, Quzhou, China. jill23liting@163.com.ORCID http://orcid.org/0000-0002-2632-7496
Weihua SunSchool of Education, Quzhou University, Quzhou, China.
Yunping LanDepartment of Anesthesiology, People's Hospital of Quzhou, No. 2 Zhong Lou Di, Kecheng District, Quzhou, China. qzmzzk@163.com.
Changxing XiaDepartment of Anesthesiology, People's Hospital of Quzhou, No. 2 Zhong Lou Di, Kecheng District, Quzhou, China.
Gongmin YuDepartment of Anesthesiology, People's Hospital of Quzhou, No. 2 Zhong Lou Di, Kecheng District, Quzhou, China.
Qinghua WuDepartment of Anesthesiology, People's Hospital of Quzhou, No. 2 Zhong Lou Di, Kecheng District, Quzhou, China.
Shufen YangDepartment of Anesthesiology, People's Hospital of Quzhou, No. 2 Zhong Lou Di, Kecheng District, Quzhou, China.
Xiaofeng XuDepartment of Anesthesiology, People's Hospital of Quzhou, No. 2 Zhong Lou Di, Kecheng District, Quzhou, China.
Quzhou City People's Hospital · CNQuzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePropofol injection pain is a very common problem during the induction of general anesthesia. The purpose of this review is to evaluate the effectiveness of dexmedetomidine for the prevention of propofol injection pain so as to provide evidence for future clinical applications.

methodsPubMed, Embase, Cochrane library, and Google Scholar databases were searched for relevant randomized controlled trials examining the use of dexmedetomidine for the prevention of propofol injection pain. The pooled risk ratio (RR) with corresponding 95% confidence intervals (CI) was calculated employing fixed-effects or random-effects models, depending upon the heterogeneity of the included trials. Because of the wide variety of interventions investigated, three comparisons of studies were established, dexmedetomidine compared with saline, lidocaine, and ketamine.

resultsCompared with saline, dexmedetomidine allowed more patients to experience no pain upon propofol injection (RR = 0.26, 95% CI (0.18, 0.38), P < 0.00001). Dexmedetomidine at doses of < 1 μg/kg did not show superiority in relieving propofol injecting pain compared with lidocaine (RR = 1.28, 95% CI (0.82, 2.00), P = 0.04). Dexmedetomidine is less effective than ketamine in reducing pain on propofol injection with a statistically significant P value of < 0.000010 (RR = 1.93, 95% CI (1.51, 2.47)). The report of adverse effects is rare, dexmedetomidine is a safe method to reduce propofol injection pain.

conclusionPretreatment with dexmedetomidine may be a useful alternative for reducing pain on propofol injection, even though dexmedetomidine is less effective than lidocaine and ketamine.

Indexed as

Anesthetics, IntravenousPropofolAnalgesics, Non-NarcoticAnesthesiaDexmedetomidineHumansPainRandomized Controlled Trials as TopicAnalgesics, Non-NarcoticAnesthetics, IntravenousDexmedetomidinePropofolAnesthesiaDexmedetomidinePainPropofol

Identifiers

PMID32385544
OpenAlexW3021613000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.